Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HTR1B | P28222 | 3/20 | 0.35 |
| ▸ | MPO | P05164 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3983271 | 0.89 | HTR1B (0.40) | HTR2ALOXL2SMN1; SMN2HTR1BMPO | |
| SCHEMBL9739681 | 0.83 | HTR2A (0.43) | HTR2ATAAR1LOXL2CYP2A6HTR1B | |
| SCHEMBL6591672 | 0.80 | ALDH1A1 (0.32) | CYP2A6ALDH1A1TSHRHSD17B10 | |
| SCHEMBL2961433 | 0.80 | TDP1 (0.37) | CYP2A6HTR1BCYP1A2HTR1DALDH1A1 | |
| SCHEMBL13183865 | 0.80 | KDM4E (0.41) | CYP1A2CYP3A4CYP2D6ALDH1A1HSD17B10 | |
| SCHEMBL6002752 | 0.77 | MAPT (0.30) | CYP2A6ALDH1A1TSHRHSD17B10MAPT | |
| SCHEMBL16684493 | 0.77 | MAPT (0.43) | GAAMAPT | |
| SCHEMBL28869124 | 0.77 | KDM4E (0.38) | ALDH1A1TSHRHSD17B10KDM4EGAA | |
| SCHEMBL7140950 | 0.77 | EGFR (0.41) | MPOCYP1A2CYP3A4CYP2D6KDM4E | |
| SCHEMBL10596740 | 0.76 | KDM4E (0.40) | ALDH1A1TSHRHSD17B10KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632861-B2 | 1-Isobenzofuranethanamine, 1-[[[3,5-bis(trifluoromethyl)phenyl]methoxy]methyl]-1,3-dihydro-N,N-dimethyl-; use in treating a disorder associated with aberrant levels of tachykinins or serotonin; nerve system disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-12-15 | — | — | US | claimed |
| WO-2009064684-A1 | SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-22 | — | — | WO | claimed |
| US-20090124613-A1 | Substituted Heterocyclic Ethers and Their Use in CNS Disorders | BRISTOL-MYERS SQUIBB COMPANY | 2009-05-14 | — | — | US | claimed |
| US-8304543-B2 | Blocking agents for organoborane compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-11-06 | — | — | US | disclosed |
| US-8304543-B2 | Blocking agents for organoborane compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-11-06 | — | — | US | disclosed |
| EP-2350099-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUND | Dow Global Technologies LLC (US) | 2011-08-03 | — | — | EP | disclosed |
| US-20110002855-A1 | PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2011-01-06 | — | — | US | disclosed |
| US-20100105910-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUNDS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-20100105910-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUNDS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2010048323-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUND | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010048323-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUND | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| EP-2162451-A2 | PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES | Neurogen Corporation (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2009003003-A2 | PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2008-12-31 | — | — | WO | disclosed |
| EP-1537122-B9 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH CORP (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-1537122-B1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH CORP (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1537122-A1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | Wyeth (US) | 2005-06-08 | — | — | EP | disclosed |
| US-6800637-B2 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | WYETH | 2004-10-05 | — | — | US | disclosed |
| US-20040138222-A1 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | WYETH | 2004-07-15 | — | — | US | disclosed |
| WO-2004024734-A1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH (US) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110002855-A1 | PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES | HRH3, HRH4, HRH1 | HTR2A 108/4885TAAR1 116/4885LOXL2 1392/4885 |
| US-20100105910-A1 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUNDS | NMBR, TBCB, GABBR1 | HTR2A 2875/4885TAAR1 276/4885LOXL2 1662/4885 |
| US-20040138222-A1 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | HTR5A, TPH1, DBH | HTR2A 23/4885TAAR1 50/4885LOXL2 4115/4885 |
| US-20090124613-A1 | Substituted Heterocyclic Ethers and Their Use in CNS Disorders | CNR1, CNR2, PMP22 | HTR2A 226/4885TAAR1 205/4885LOXL2 2893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.